| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxart, Inc. (VXRT) has 11 insiders with recent SEC Form 4 filings, including 15 buys and 2 sells. VXRT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 2.61M | $1.83M | - | |
| CFO | 1.00M | $700.0K | - | |
| Other | 958.0K | $670.6K | - | |
| VP | 923.2K | $646.2K | - | |
| VP | 791.8K | $554.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Heron Elaine J | Director | Buy | 40,000 | $0.40 | $15,921.40 | +29.3% | |
| Nov 17, 2025 | Watson W. Mark | Director | Buy | 20,000 | $0.41 | $8,185.00 | +9.0% | |
| Aug 15, 2025 | Finney Kevin | Director | Buy | 166,668 | $0.37 | $61,933.84 | +35.1% | |
| Jul 29, 2025 | Watson W. Mark | Director | Buy | 10,000 | $0.41 | $4,050.00 | +10.6% | |
| May 19, 2025 | Lo Steven | President, Chief Exec Officer | Buy | 100,000 | $0.49 | $49,000.00 | New | |
| Jun 18, 2024 | Watson W. Mark | Director | Buy | 20,000 | $0.68 | $13,578.00 | +34.4% | |
| Dec 28, 2022 | Watson W. Mark | Director | Buy | 20,000 | $0.76 | $15,140.00 | New | |
| Jun 22, 2022 | Ahmad Fuad | Interim CFO | Buy | 5,000 | $3.22 | $16,100.00 | New | |
| Jan 10, 2022 | Yedid Robert A. | Director | Sell | 1,500 | $6.01 | $9,015.15 | -100% | |
| Nov 30, 2021 | Echerd Margaret | SVP, Principal Accntng Officer | Sale+OE | 3,602 | $8.00 | $28,816.00 | -100% |